IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 333 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $142,000 | -25.3% | 2,400 | -40.0% | 0.00% | -33.3% |
| Q1 2020 | $190,000 | -22.1% | 4,000 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $244,000 | +1.7% | 4,000 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $240,000 | -7.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $258,000 | -20.6% | 4,000 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $325,000 | +49.8% | 4,000 | -0.2% | 0.00% | +33.3% |
| Q4 2018 | $217,000 | +4.8% | 4,010 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $207,000 | +24.0% | 4,010 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $167,000 | -5.6% | 4,010 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $177,000 | -12.4% | 4,010 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $202,000 | -0.5% | 4,010 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $203,000 | -0.5% | 4,010 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $204,000 | +26.7% | 4,010 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $161,000 | +16000.0% | 4,010 | +40000.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -99.0% | 10 | -99.8% | 0.00% | -100.0% |
| Q2 2016 | $98,000 | – | 4,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |